Keywords: interim, data, clofarabine, aml, trial, bioenvision, usa

Interim data from clofarabine AML trial

Article | 03 May 2004

Print This

Bioenvision of the USA has reported preliminary Phase II data from a European Phase II trial investigating its clofarabine as ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in